Globus Medical Stock Today
| GMED Stock | USD 79.58 0.44 0.55% |
PerformanceVery Weak
| Odds Of DistressLow
|
Globus Medical is trading at 79.58 as of the 25th of February 2025, a 0.55 percent decrease since the beginning of the trading day. The stock's lowest day price was 78.19. Globus Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 25th of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of August 2012 | Category Healthcare | Classification Health Care |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. The company has 115.11 M outstanding shares of which 2.18 M shares are currently shorted by private and institutional investors with about 1.82 trading days to cover. More on Globus Medical
Moving together with Globus Stock
Moving against Globus Stock
| 0.4 | EDIT | Editas Medicine Earnings Call Tomorrow | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Globus Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | David Paul | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP Midcap 400, Obamacare, Obamacare Repeal, Baby Boomer Prospects, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsGlobus Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Globus Medical's financial leverage. It provides some insight into what part of Globus Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Globus Medical (GMED) is traded on New York Stock Exchange in USA. It is located in 2560 General Armistead Avenue, Audubon, PA, United States, 19403 and employs 5,300 people. Globus Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.01 B. Globus Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 115.11 M outstanding shares of which 2.18 M shares are currently shorted by private and institutional investors with about 1.82 trading days to cover.
Globus Medical currently holds about 408.01 M in cash with 520.64 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.1.
Check Globus Medical Probability Of Bankruptcy
Ownership AllocationGlobus Medical has a total of 115.11 Million outstanding shares. The majority of Globus Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Globus Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Globus Medical. Please pay attention to any change in the institutional holdings of Globus Medical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Globus Ownership Details
Globus Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Millennium Management Llc | 2024-12-31 | 1.7 M | |
| Hawk Ridge Management Llc | 2024-12-31 | 1.7 M | |
| Citadel Advisors Llc | 2024-09-30 | 1.6 M | |
| Axa Sa | 2024-12-31 | 1.4 M | |
| Norges Bank | 2024-12-31 | 1.4 M | |
| Bank Of New York Mellon Corp | 2024-12-31 | 1.4 M | |
| William Blair Investment Management, Llc | 2024-12-31 | 1.2 M | |
| Camber Capital Management Llc | 2024-12-31 | 1.2 M | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 1.2 M | |
| Vanguard Group Inc | 2024-12-31 | 10.9 M | |
| Blackrock Inc | 2024-12-31 | 10.6 M |
Globus Medical Historical Income Statement
Globus Stock Against Markets
Globus Medical Corporate Directors
| Steve Zarrilli | Independent Director | Profile | |
| Ann Rhoads | Independent Director | Profile | |
| James Tobin | Independent Director | Profile | |
| Daniel Lemaitre | Independent Director | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.827 | Earnings Share 0.75 | Revenue Per Share | Quarterly Revenue Growth 0.066 | Return On Assets |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.